As such, several lines of evidence show that increased expression of CEP131 is correlated with higher histologic grades of breast cancer and poor overall survival in hepatocellular carcinoma and advanced Tumor-Node-Metastasis stage of non-small cell lung cancer [14–16]. This evidence concerns the gene CEP131 and breast cancer.